{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:24:34Z","timestamp":1760300674619,"version":"3.41.2"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Inositol polyphosphate-4-phosphatase type II (INPP4B) has been identified as a tumor suppressor, while little is known about its expression and function in multiple myeloma (MM). In this study, we evaluated the expression of <jats:italic>INPP4B<\/jats:italic> in 28 cases of newly diagnosed MM patients and 42 cases of extramedullary plasmacytoma (EMP) patients compared with normal plasma cells and found that low INPP4B expression was correlated with poor outcomes in MM patients. Moreover, expression of INPP4B in seven MM cell lines was all lower than that in normal plasma cells. In addition, loss of function of INPP4B promoted cell proliferation in MM cells; however, gain of function suppressed MM cells proliferation and arrested the cell cycle at G0\/G1 phage. Meanwhile, knockdown of INPP4B enhanced resistance, but overexpression promoted sensitivity to bortezomib treatment in MM cells. Mechanistically, we found that <jats:italic>INPP4B<\/jats:italic> exerted its role <jats:italic>via<\/jats:italic> inhibiting the phosphorylation of Akt at lysine 473 but not threonine 308, which attenuated the activation of the PI3K\/Akt\/mammalian target of rapamycin (mTOR) signaling pathway. Therefore, we identified an inhibitory effect of INPP4B in MM, and our findings suggested that loss of INPP4B expression is a risk factor of aggressive MM.<\/jats:p>","DOI":"10.3389\/fonc.2021.785297","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T08:39:21Z","timestamp":1641371961000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor in Multiple Myeloma"],"prefix":"10.3389","volume":"11","author":[{"given":"Yafei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1159\/000520312","article-title":"Multiple Myeloma: Molecular Pathogenesis and Disease Evolution","volume":"44","author":"Heider","year":"2021","journal-title":"Oncol Res Treat"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.04.026","article-title":"Response to Novel Drugs Before and After Allogeneic Stem Cell Transplantation in Patients With Relapsed Multiple Myeloma","volume":"25","author":"Lopez-Corral","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1358\/dot.2021.57.10.3313853","article-title":"Daratumumab for the Treatment of Multiple Myeloma","volume":"57","author":"Goldsmith","year":"2021","journal-title":"Drugs Today (Barc)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2021.101306","article-title":"Clinical Experience of CAR T Cells for Multiple Myeloma","volume":"34","author":"Simmons","year":"2021","journal-title":"Best Pract Res Clin Haematol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102284","article-title":"Roadmap to Cure Multiple Myeloma","volume":"100","author":"Rodriguez-Otero","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbior.2021.100817","article-title":"The INPP4B Paradox: Like PTEN, But Different","volume":"82","author":"Hamila","year":"2021","journal-title":"Adv Biol Regul"},{"key":"B7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/978-94-007-5025-8_12","article-title":"Inositol Polyphosphate Phosphatases in Human Disease","volume":"362","author":"Hakim","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BSR20160432","article-title":"Regulation of PI3K Effector Signalling in Cancer by the Phosphoinositide Phosphatases","volume":"37","author":"Rodgers","year":"2017","journal-title":"Biosci Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1356","article-title":"High Resolution Genomic Analysis of Sporadic Breast Cancer Using Array-Based Comparative Genomic Hybridization","volume":"7","author":"Naylor","year":"2005","journal-title":"Breast Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbrc.2017.02.012","article-title":"Functional Identification of a Novel Transcript Variant of INPP4B in Human Colon and Breast Cancer Cells","volume":"485","author":"Croft","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.7150\/jca.58397","article-title":"INPP4B Exerts a Dual Role in Gastric Cancer Progression and Prognosis","volume":"12","author":"Wu","year":"2021","journal-title":"J Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.gene.2017.06.001","article-title":"IRF2-INPP4B Axis Participates in the Development of Acute Myeloid Leukemia by Regulating Cell Growth and Survival","volume":"627","author":"Zhang","year":"2017","journal-title":"Gene"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5359","article-title":"INPP4B Is Upregulated and Functions as an Oncogenic Driver Through SGK3 in a Subset of Melanomas","volume":"6","author":"Chi","year":"2015","journal-title":"Oncotarget"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13595","article-title":"INPP4B Restrains Cell Proliferation and Metastasis via Regulation of the PI3K\/AkT\/SGK Pathway","volume":"22","author":"Chen","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2015.06.006","article-title":"Phosphoinositide Signaling in Cancer: INPP4B Akt(s) Out","volume":"21","author":"Woolley","year":"2015","journal-title":"Trends Mol Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1038\/s41467-021-23241-6","article-title":"INPP4B Promotes PI3Kalpha-Dependent Late Endosome Formation and Wnt\/beta-Catenin Signaling in Breast Cancer","volume":"12","author":"Rodgers","year":"2021","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.06.006","article-title":"Evidence That Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor That Inhibits PI3K Signaling","volume":"16","author":"Gewinner","year":"2009","journal-title":"Cancer Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2014.00064","article-title":"Targeting PI3K\/Akt\/mTOR Signaling in Cancer","volume":"4","author":"Porta","year":"2014","journal-title":"Front Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scisignal.aan6282","article-title":"C-Reactive Protein Promotes Bone Destruction in Human Myeloma Through the CD32-P38 MAPK-Twist Axis","volume":"10","author":"Yang","year":"2017","journal-title":"Sci Signal"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-1037-6","article-title":"Proteasome Inhibitor Induced SIRT1 Deacetylates GLI2 to Enhance Hedgehog Signaling Activity and Drug Resistance in Multiple Myeloma","volume":"39","author":"Xie","year":"2020","journal-title":"Oncogene"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-018-0705-7","article-title":"Modulator of the PI3K\/Akt Oncogenic Pathway Affects mTOR Complex 2 in Human Adenocarcinoma Cells","volume":"37","author":"Curless","year":"2019","journal-title":"Invest New Drugs"},{"key":"B22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s10020-020-0146-6","article-title":"The Role of RICTOR Amplification in Targeted Therapy and Drug Resistance","volume":"26","author":"Zhao","year":"2020","journal-title":"Mol Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41467-020-14430-w","article-title":"Mtorc2-AkT Signaling to ATP-Citrate Lyase Drives Brown Adipogenesis and De Novo Lipogenesis","volume":"11","author":"Martinez Calejman","year":"2020","journal-title":"Nat Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2174\/0929867321666140601204513","article-title":"Targeting the Phosphatidylinositol 3-Kinase\/AkT Pathway for the Treatment of Multiple Myeloma","volume":"21","author":"Zhu","year":"2014","journal-title":"Curr Med Chem"},{"key":"B25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12885-021-08143-6","article-title":"Expression and Functional Characterization of INPP4B in Gallbladder Cancer Patients and Gallbladder Cancer Cells","volume":"21","author":"Wu","year":"2021","journal-title":"BMC Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-603555","article-title":"Inositol Polyphosphate 4-Phosphatase II (INPP4B) Is Associated With Chemoresistance and Poor Outcome in AML","volume":"125","author":"Rijal","year":"2015","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M508361200","article-title":"mTOR.RICTOR Is the Ser473 Kinase for Akt\/protein Kinase B in 3T3-L1 Adipocytes","volume":"280","author":"Hresko","year":"2005","journal-title":"J Biol Chem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41467-021-21386-y","article-title":"Targeting NSD2-Mediated SRC-3 Liquid-Liquid Phase Separation Sensitizes Bortezomib Treatment in Multiple Myeloma","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.785297\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T08:39:25Z","timestamp":1641371965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.785297\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":28,"alternative-id":["10.3389\/fonc.2021.785297"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.785297","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2022,1,5]]},"article-number":"785297"}}